Logo image of CMRC

COMMERCE.COM INC (CMRC) Stock Fundamental Analysis

USA - NASDAQ:CMRC - US08975P1084 - Common Stock

5.09 USD
+0.17 (+3.46%)
Last: 9/26/2025, 8:00:00 PM
5.14 USD
+0.05 (+0.98%)
After Hours: 9/26/2025, 8:00:00 PM
Fundamental Rating

3

CMRC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 87 industry peers in the IT Services industry. CMRC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CMRC has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year CMRC was profitable.
CMRC had a positive operating cash flow in the past year.
In the past 5 years CMRC always reported negative net income.
In the past 5 years CMRC reported 4 times negative operating cash flow.
CMRC Yearly Net Income VS EBIT VS OCF VS FCFCMRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

With a Return On Assets value of -5.99%, CMRC is not doing good in the industry: 67.82% of the companies in the same industry are doing better.
CMRC has a worse Return On Equity (-46.74%) than 74.71% of its industry peers.
Industry RankSector Rank
ROA -5.99%
ROE -46.74%
ROIC N/A
ROA(3y)-17.34%
ROA(5y)-15.95%
ROE(3y)-213.47%
ROE(5y)-142.73%
ROIC(3y)N/A
ROIC(5y)N/A
CMRC Yearly ROA, ROE, ROICCMRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

CMRC has a Gross Margin of 78.06%. This is amongst the best in the industry. CMRC outperforms 95.40% of its industry peers.
CMRC's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for CMRC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
CMRC Yearly Profit, Operating, Gross MarginsCMRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

4

2. Health

2.1 Basic Checks

CMRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CMRC has more shares outstanding
CMRC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CMRC has an improved debt to assets ratio.
CMRC Yearly Shares OutstandingCMRC Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CMRC Yearly Total Debt VS Total AssetsCMRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of -0.57, we must say that CMRC is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.57, CMRC is doing worse than 81.61% of the companies in the same industry.
The Debt to FCF ratio of CMRC is 6.27, which is on the high side as it means it would take CMRC, 6.27 years of fcf income to pay off all of its debts.
CMRC has a Debt to FCF ratio (6.27) which is comparable to the rest of the industry.
CMRC has a Debt/Equity ratio of 4.06. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 4.06, CMRC is doing worse than 85.06% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.06
Debt/FCF 6.27
Altman-Z -0.57
ROIC/WACCN/A
WACC7.45%
CMRC Yearly LT Debt VS Equity VS FCFCMRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

CMRC has a Current Ratio of 2.13. This indicates that CMRC is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.13, CMRC is in the better half of the industry, outperforming 62.07% of the companies in the same industry.
A Quick Ratio of 2.13 indicates that CMRC has no problem at all paying its short term obligations.
CMRC has a better Quick ratio (2.13) than 63.22% of its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 2.13
CMRC Yearly Current Assets VS Current LiabilitesCMRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 33.33% over the past year.
The Revenue has been growing slightly by 4.05% in the past year.
The Revenue has been growing by 24.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)4.05%
Revenue growth 3Y14.83%
Revenue growth 5Y24.32%
Sales Q2Q%3.18%

3.2 Future

CMRC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.37% yearly.
The Revenue is expected to grow by 4.71% on average over the next years.
EPS Next Y-23.9%
EPS Next 2Y5.22%
EPS Next 3Y14.37%
EPS Next 5YN/A
Revenue Next Year3.24%
Revenue Next 2Y3.95%
Revenue Next 3Y4.71%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CMRC Yearly Revenue VS EstimatesCMRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
CMRC Yearly EPS VS EstimatesCMRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.18, CMRC is valued on the expensive side.
Based on the Price/Earnings ratio, CMRC is valued a bit cheaper than 72.41% of the companies in the same industry.
When comparing the Price/Earnings ratio of CMRC to the average of the S&P500 Index (27.54), we can say CMRC is valued slightly cheaper.
A Price/Forward Earnings ratio of 16.42 indicates a correct valuation of CMRC.
CMRC's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CMRC is cheaper than 71.26% of the companies in the same industry.
CMRC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.05.
Industry RankSector Rank
PE 18.18
Fwd PE 16.42
CMRC Price Earnings VS Forward Price EarningsCMRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

68.97% of the companies in the same industry are cheaper than CMRC, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CMRC is valued a bit cheaper than 75.86% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.36
EV/EBITDA 228.14
CMRC Per share dataCMRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

A more expensive valuation may be justified as CMRC's earnings are expected to grow with 14.37% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.22%
EPS Next 3Y14.37%

0

5. Dividend

5.1 Amount

No dividends for CMRC!.
Industry RankSector Rank
Dividend Yield N/A

COMMERCE.COM INC

NASDAQ:CMRC (9/26/2025, 8:00:00 PM)

After market: 5.14 +0.05 (+0.98%)

5.09

+0.17 (+3.46%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners70.06%
Inst Owner ChangeN/A
Ins Owners10.48%
Ins Owner Change7.18%
Market Cap410.97M
Analysts70
Price Target7.48 (46.95%)
Short Float %7.96%
Short Ratio6.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.46%
Min EPS beat(2)15%
Max EPS beat(2)29.93%
EPS beat(4)4
Avg EPS beat(4)68.16%
Min EPS beat(4)15%
Max EPS beat(4)168.48%
EPS beat(8)8
Avg EPS beat(8)76.94%
EPS beat(12)12
Avg EPS beat(12)68.23%
EPS beat(16)14
Avg EPS beat(16)54.08%
Revenue beat(2)0
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-2.04%
Max Revenue beat(2)-0.64%
Revenue beat(4)0
Avg Revenue beat(4)-1.44%
Min Revenue beat(4)-2.04%
Max Revenue beat(4)-0.64%
Revenue beat(8)2
Avg Revenue beat(8)-0.7%
Revenue beat(12)4
Avg Revenue beat(12)-0.63%
Revenue beat(16)8
Avg Revenue beat(16)0.24%
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.18
Fwd PE 16.42
P/S 1.22
P/FCF 16.36
P/OCF 12.89
P/B 10.6
P/tB N/A
EV/EBITDA 228.14
EPS(TTM)0.28
EY5.5%
EPS(NY)0.31
Fwd EY6.09%
FCF(TTM)0.31
FCFY6.11%
OCF(TTM)0.39
OCFY7.76%
SpS4.18
BVpS0.48
TBVpS-0.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.99%
ROE -46.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.06%
FCFM 7.44%
ROA(3y)-17.34%
ROA(5y)-15.95%
ROE(3y)-213.47%
ROE(5y)-142.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
F-Score6
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 4.06
Debt/FCF 6.27
Debt/EBITDA 103.92
Cap/Depr 45.32%
Cap/Sales 2.01%
Interest Coverage N/A
Cash Conversion 2103.63%
Profit Quality N/A
Current Ratio 2.13
Quick Ratio 2.13
Altman-Z -0.57
F-Score6
WACC7.45%
ROIC/WACCN/A
Cap/Depr(3y)35.32%
Cap/Depr(5y)44.65%
Cap/Sales(3y)1.44%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y-23.9%
EPS Next 2Y5.22%
EPS Next 3Y14.37%
EPS Next 5YN/A
Revenue 1Y (TTM)4.05%
Revenue growth 3Y14.83%
Revenue growth 5Y24.32%
Sales Q2Q%3.18%
Revenue Next Year3.24%
Revenue Next 2Y3.95%
Revenue Next 3Y4.71%
Revenue Next 5YN/A
EBIT growth 1Y65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year80.8%
EBIT Next 3Y46.98%
EBIT Next 5YN/A
FCF growth 1Y139.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y153.52%
OCF growth 3YN/A
OCF growth 5YN/A